Effects of early corticosteroid use in patients with severe coronavirus disease 2019

BMC Infectious Diseases

Table 4 Clinical outcomes in the early use and late use groups

	Early use group (n = 12)	Late use group (n = 10)	p-value
Time from diagnosis to discharge	27.8 ± 12.2	57.4 ± 22.5	0.024
Time from symptom to PCR-negative	25.0 (22.0–38.0)	37.5 ± (28.0–50.0)	0.190
Time from symptom to discharge	32.4 ± 13.1	60.0 ± 21.5	0.030
Time from corticosteroid use to discharge	25.6 ± 12.4	46.3 ± 22.7	0.096
Length of hospital stay	26.0 ± 11.4	53.9 ± 11.4	0.033
Overall mortality, No./Total (%)	1/12 (8.3%)	3/10 (30%)	0.293

PCR polymerase chain reaction
Continuous variables with normal distribution are shown as mean ± SD. Group comparisons were performed using independent sample t-test. Continuous non-normal distribution variables are shown as median interquartile range. and Mann-Whitney tests were used to compare the difference between groups

ISSN: 1471-2334